Delivery Order SPE2DB20D2104-SPE2DB26FMANJ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $32,285.78. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and represents performance at the contractor's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 16, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed-price contract with a ceiling value of $1,797.10 and an ultimate completion date of July 17, 2025. The award was made through open competition with no set-aside designation. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,186.16 by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is set for July 23, 2025, with performance occurring at...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for 60 tablets of Eliquis 5 mg at a ceiling value of $20,974.50. This competitively awarded, non-set-aside contract was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The firm fixed price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 25, 2025, for 60 tablets of Eliquis 5 mg. This competitively awarded, firm fixed-price contract has a ceiling value of $6,351.66 and an ultimate completion date of June 26, 2025. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The delivery order, valued at $1,965.60 with a firm fixed price, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a competitive, non-set-aside transaction and will be performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count supply) with a ceiling value of $15,544.58. The contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMANJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging). This firm fixed-price delivery order, valued at $15,328.94, is a non-set-aside award and represents a continuation of the company's significant role in federal medical procurement. The order is expected to be completed by October 22, 2025, with performance occurring at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, evidenced by its extensive portfolio of delivery orders across multiple therapeutic domains, positions it as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 10/21/25 |